Joined Today: 0

CPRX Catalyst Pharmaceutical, Stock Message Board

All Messages

CPRX Message Board Home | Join The CPRX Group |

#6: CPRX Stock News : Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction
TheMachine	May 30, 2009 11:26:46 PM
Management will host Conference Call at 9:00 AM ET Today CORAL GABLES, Fla., May 29 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) today announced... view message ignore post recommend post

#5: Catalyst Pharmaceutical Partners, Inc. Announces a $4.5 Million Registered Direct Common Stock Offering
TheMachine	September 20, 2008 01:10:13 AM
CORAL GABLES, Fla., Sept. 12 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX), a biopharmaceutical company that acquires,... view message ignore post recommend post

#4: Catalyst Pharmaceutical Partners Reports First Quarter 2008 Financial Results
TheMachine	May 21, 2008 01:16:48 AM
Frank Greenway, M.D. Joins Catalyst's Scientific Advisory Board Andrew Forman Retained As Business Development & Investor Relations Consultant CORAL GABLES,... view message ignore post recommend post

#3: Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance
TheMachine	May 21, 2008 01:16:04 AM
Patrick Kenny, Former Senior Clinical Research Associate at Kendle International, Inc., Joins Catalyst CORAL GABLES, Fla., March 5 /PRNewswire-FirstCall/ --... view message ignore post recommend post

#2: Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction
FastFun	December 7, 2007 07:25:41 PM
- Study Demonstrates Statistically Significant Efficacy vs. Placebo - - Trial Conducted Under Direction of New York University School of Medicine - CORAL GABLES, Fla., Dec. 7... view message ignore post recommend post

#1: CPRX, Catalyst Pharmaceutical Partners Reports First Quarter 2007 Financial Results
Jason	May 29, 2007 08:17:06 AM
Company Successfully Completes Bioequivalence Study Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX Drugstocks) today reported financial results for the quarter ended March 31, 2007. First... view message ignore post recommend post

Group Home | Login if you want to post a message